These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 13171645)

  • 1. [Neutralizing power of sample anti-oedematiens, anti-septicum and anti-histolyticum serums].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; READE G
    Ann Inst Pasteur (Paris); 1954 Apr; 86(4):418-24. PubMed ID: 13171645
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-gangrene serums. Persistence of anti-septicum and anti-oedematiens immunity after the arrest of corresponding immunization].
    GUILLAUMIE M; KREGUER A; GEOFFROY M; VENTRE F
    Rev Immunol Ther Antimicrob; 1960; 24():581-605. PubMed ID: 13709613
    [No Abstract]   [Full Text] [Related]  

  • 3. [New researches on the evaluation of the anti-histolyticum and anti-septicum activity of different sera].
    GUILLAUMIE M; KREGUER A; GEOFFROY
    Ann Inst Pasteur (Paris); 1954 Jan; 86(1):38-52. PubMed ID: 13158926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antitoxic activity of the serum of animals receiving for several months injections of septicum toxin or histolyticum anatoxin, then simultaneous injections of septicum toxin and histolyticum anatoxin].
    GUILLAUMIE M; KREGUER A; GEOFFROY M
    Ann Inst Pasteur (Paris); 1954 Feb; 86(2):197-203. PubMed ID: 13158945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-cell and anti-organ serums. XI. General conclusions in the study of heteroimmune anti-cell and anti-organ serums of guinea pig].
    CAJANO A
    Haematologica; 1954; 38(3):385-424. PubMed ID: 13162310
    [No Abstract]   [Full Text] [Related]  

  • 6. The local and general effects of cultures and culture-filtrates of Clostridium oedematiens, CL. septicum, CL. sporogenes and CL. histolyticum.
    AIKAT BK; DIBLE JH
    J Pathol Bacteriol; 1960 Apr; 79():227-41. PubMed ID: 13792165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on the preparation of anti-histolyticum serum].
    GUILLAUMIE M; KREGUER A; FABRE M; BECOULET G
    Rev Immunol Ther Antimicrob; 1952; 16(4-5):257-73. PubMed ID: 13014711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental studies on anti-cellular and anti-organ serums; anti-spleen serum].
    CAJANO A; MAUREA C
    Haematologica; 1954; 38(1):111-49. PubMed ID: 13151533
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the absorption of anti-B from raw serums for the production of group-and factor-specific test serums].
    Dietz G
    Z Gesamte Hyg; 1966 Nov; 12(11):986-8. PubMed ID: 5979660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-cell and anti-organ serums; experimental studies].
    CAJANO A; MAUREA C
    Haematologica; 1954; 38(3):325-62. PubMed ID: 13162308
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-cell and anti-organ serums; experimental studies; mixed antiserums].
    CAJANO A; MAUREA C
    Haematologica; 1954; 38(2):155-90. PubMed ID: 13162299
    [No Abstract]   [Full Text] [Related]  

  • 12. OBSERVATIONS ON THE BLOOD GROUPING SERUMS, (ANTI-A, ANTI-B AND ANTI-RHO.) PREPARED FROM ANIMALS.
    HAYAKAWA Z
    Nihon Hoigaku Zasshi; 1963 Sep; 17():367-73. PubMed ID: 14062043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isolation of antibody active substance from anti-M and anti-N rabbit serums by means of preparative electrophoresis].
    PETER H; HANSER A; VON DER EMDEN A
    Z Immun exp ther; 1954 Mar; 111(1):44-56. PubMed ID: 13179734
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gelation of normal serums or immune serums under the influence of sodium salicylate and various bodies].
    DELAUNAY A; DE ROQUEFEUIL C
    C R Hebd Seances Acad Sci; 1954 May; 238(19):1933-5. PubMed ID: 13161264
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purification and enzymatic disantigenization of antitoxic serums and plasmas. III. Theoretical evaluation of antitoxic and anaphylactic function of antitoxic serums and plasmas].
    CORDON F; MARTINEZ A
    Microbiol Esp; 1957; 10(1):69-98. PubMed ID: 13464448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation of antibodies neutralizing the odorant power of certain no 1 ecules with low molecular weights].
    LOISELEUR J; PETIT M
    C R Hebd Seances Acad Sci; 1960 Nov; 251():2436-7. PubMed ID: 13763222
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
    Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
    J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical considerations on the removal of euglobulin and lipoprotein complexes from immune serums].
    PANDOLFI C
    Boll Soc Ital Biol Sper; 1953; 29(9-10-11):1818-9. PubMed ID: 13140731
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation of an anti-human serum with great precipitating power and specificity].
    KONDI V; IACOBESCU A; BALAN S; MITRICA N
    Med Interna (Bucur); 1959 Nov; 11():1751-3. PubMed ID: 14410830
    [No Abstract]   [Full Text] [Related]  

  • 20. [The evaluation of agglutinating immune serums by the filter paper method].
    VAJDA G; BACKHAUSZ R
    Acta Microbiol Acad Sci Hung; 1954; 1(4):349-58. PubMed ID: 13206688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.